Announcements Trials
Browse Landscape

Phase

Phase 1 10Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 19Breast 1

Conditions

Breast Neoplasms 3863Motor Activity 228Neoplasms 201Prostatic Neoplasms 167Colorectal Neoplasms 146Lung Neoplasms 139Lymphedema 125Fatigue 104Ovarian Neoplasms 98Carcinoma, Intraductal, Noninfiltrating 94Colonic Neoplasms 86Breast Cancer Lymphedema 86Pain 81Breast Cancer Female 76Anxiety Disorders 76Uterine Cervical Neoplasms 73Depression 70Triple Negative Breast Neoplasms 66Breast Carcinoma In Situ 66Head and Neck Neoplasms 55Pain, Postoperative 54Obesity 54Neoplasm Metastasis 48Melanoma 42Endometrial Neoplasms 39Pancreatic Neoplasms 38Lymphoma 38Carcinoma, Non-Small-Cell Lung 34Sleep Initiation and Maintenance Disorders 33Sarcoma 33

Interventions

Surveys and Questionnaires 1Focus Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Uveal Melanoma × Breast × Clear all
NCT04118062 2025-09-19

Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)

Institut Curie

Phase NA Completed
128 enrolled
BreastDermatologic

Uveal Melanoma, Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡